按设备类型、最终用户、技术、应用和适应症分類的骨内输注设备市场—2025年至2032年全球预测

预计到 2032 年，骨内注射装置市场将成长至 90.1 亿美元，复合年增长率为 6.51%。

关键市场统计数据
基准年 2024	54.3亿美元
预计年份：2025年	57.9亿美元
预测年份 2032	90.1亿美元
复合年增长率 (%)	6.51%

临床和商业性因素推动了骨内输液装置在重症监护和营运环境中的应用。

骨内输液装置在急诊护理中发挥着至关重要的作用，因为血管通路至关重要且时间紧迫。当週边静脉通路无法使用或需要快速復苏时，医护人员会依靠这些装置来确保在急诊、院前急诊、手术室、加护病房甚至野战医疗中建立可靠的骨内通路。技术进步使该领域从基本的手动针头发展到机械穿刺系统和电池驱动钻头，旨在缩短穿刺时间、降低穿刺误差并提高高压临床环境下的首次穿刺成功率。

本篇采纳分析为影响设备选择和采纳的临床需求、技术差异化和采购考量提供了一个架构。它重点关注设备的人体工学、插入可靠性、临床医生培训以及与下游工作流程（例如液体復苏、药物给药和诊断采样）的交互作用。本文旨在为临床医生、采购主管和产品负责人提供一份简明指南，以评估设备功能如何与治疗路径、监管要求和营运限制相符。在此背景下，后续章节将讨论结构性变化、关税的影响、细分市场洞察、区域趋势、竞争格局以及基于一手和二手资讯的实用建议。

技术创新、不断发展的临床医生培训以及供应链韧性如何共同重塑骨内装置的选择和临床应用。

骨内器械产业正经历一系列变革，这些变革正在重塑产品设计重点、采购标准和临床工作流程。插入机制和便携性的进步正在缩小院内和院外操作能力之间的差距。新一代器械越来越注重单手操作、深度可控插入以及增强的整合安全功能，以减少併发症并简化训练。同时，采购部门要求器械能够在包括成人、儿童、新生儿和老年人在内的不同患者群体中提供一致的性能，这迫使製造商扩展产品系列併采用模组化系统。

同时，为降低供应中断的风险，医疗器材供应链和製造策略正朝着地域多角化和组件冗余的方向发展。支付者和医疗系统日益重视医疗品质指标和器材相关不利事件报告，使得临床证据的产生和上市后监测成为越来越重要的差异化因素。此外，基于模拟的培训和能力检验计画的普及提高了临床医生的信心和首次手术成功率，从而促进了这些技术在急诊医疗服务和门诊手术领域的广泛应用。这些协同趋势为製造商在使用者体验、服务提供和证据包方面进行创新创造了机会，同时也迫使采购者评估整体拥有成本、临床结果和生命週期支援。

评估关税趋势对骨内输注装置的筹资策略、本地化生产和临床应用的影响

美国2025年可能加征关税，为采购、製造和购买环节的相关人员增加了一层政策风险，因为关税政策的变化可能会对复杂的医疗技术供应链产生连锁反应。针对医疗器材组件和成品的关税可能会立即给依赖进口设备和原材料的企业带来成本压力，促使采购部门重新评估供应商合约、库存缓衝和国内采购方案。作为应对措施，一些製造商可能会加快关键製造环节的在地化进程，或加强与国内契约製造製造商的合作关係，以确保价格稳定和交货期。

除了直接的价格影响外，关税还会影响产品组合、包装和运输路线选择等策略决策，以最大限度地降低关税负担。经销商和集团采购组织可能会寻求修改合约条款，以分担关税相关的成本波动；医疗机构可能会调整采购计划，以利用现有库存或协商价格。重点，关税将促使企业投资于马达、电池和特殊合金等关键零件的替代供应链，从而影响设备设计和前置作业时间。从临床角度来看，政策引发的供应中断可能会限制关键时期设备的可用性，因此冗余备份和紧急时应对计画至关重要。总而言之，关税政策的发展应促使製造商和采购商积极主动地实现采购管道多元化，检验替代供应商，并制定正式的升级程序，以维持临床服务的连续性并降低营运风险。

细分市场分析揭示了设备类型、最终用户环境、技术选择、临床应用和适应症如何驱动采购和采用差异化。

详细的細項分析揭示了设备技术和最终用户环境如何驱动产品需求和采用路径。基于设备类型，相关人员评估各种选项，例如电池驱动钻头、手动针头、气动和弹簧式自动插入装置。每种配置在速度、控制和使用者熟悉度方面各有优劣。基于最终用户，配置包括门诊中心、急诊医疗服务、医院和军队。在门诊中心中，重点是门诊手术中心和医生诊所，而急诊医疗服务则涵盖空中救护和院前急诊服务。医院进一步细分为急诊室、加护病房(ICU) 和手术室。急诊室本身又分为成人急诊和儿科急诊科，ICU 又分为成人 ICU、新生儿 ICU 和儿科 ICU。手术室的应用场景分为一般外科和整形外科，而军事应用则区分为战地支援医院和野战医疗单位。

从技术角度来看，设备的选择取决于特定环境所需的性能范围。依技术划分，市面上的设备包括电池驱动、手动、气动和弹簧驱动设备；电池驱动解决方案又可细分为可充电电池和一次性电池；气动系统则分为空气驱动和气体驱动两种。应用方面的具体要求进一步缩小了产品选择范围。根据应用领域，临床医生会选择用于心臟麻痹、肿瘤、整形外科、小儿科和创伤护理的设备。心臟麻痹的应用场景包括院内和院外；肿瘤科应用应涵盖骨髓切片检查和化疗支持；整形外科应涵盖骨折修復和关节重建；小儿科应针对儿童、婴儿和新生儿；创伤护理应用应涵盖钝性创伤和穿透性创伤。最后，临床适应症也至关重要。根据适应症，器械的选择取决于多种情况，例如心臟麻痹、低血容量性休克、脓毒症和创伤，每种情况都有其独特的手术时机、入路部位选择和后续治疗需求。整合这些细分维度表明，一刀切的产品很少能满足各种不同的应用场景，客製化的设计、培训和支援模式对于器械的推广至关重要。

不同地区在监管、采购和临床培训方面的差异将如何重塑骨内器械的产品策略和分销模式？

区域趋势将在塑造骨内输注装置的监管路径、报销框架、培训系统和供应链结构方面发挥关键作用。在美洲，买家优先考虑的是快速整合到重症监护中、广泛普及的模拟培训中心以及透过综合医疗保健系统和大型经销商进行集中采购，他们更倾向于选择具有强有力临床证据和可扩展服务模式的装置。在欧洲、中东和非洲地区（EMEA），复杂的监管体系和多样化的报销政策造成了不同的市场准入条件。欧洲市场倾向于优先考虑临床结果和上市后监测，而中东和北非地区（MENA）则更注重装置的稳健性和供应的连续性，尤其是在偏远和恶劣的环境中。在亚太地区，医院的快速扩张、重症监护能力的提升以及大规模的军事现代化项目正在推动市场需求，但打入市场策略必须考虑到不同的监管要求、当地的生产奖励以及不同的临床医生培训标准。

在全部区域，当地的製造能力、关税制度和物流基础设施都会影响前置作业时间和库存策略。区域采购联盟和竞标流程倾向于那些能够提供透明的生命週期支援和培训伙伴关係的製造商。此外，临床指南和院前急救模式的采用因地区而异，这会影响医院急诊和院前/军事部署所需设备的细分。因此，制定能够将设备性能与当地临床工作流程、监管要求和采购机制相匹配的客製化价值提案，对于成功的区域策略至关重要。

对骨内植入装置供应商的商业性成功所依据的证据、训练和供应链合作伙伴关係进行竞争性分析

骨内植入器材领域的竞争格局呈现出多元化的格局，既有成熟的器材製造商，也有技术驱动的新兴参与企业，还有提供硬体销售、训练和售后支援的服务型供应商。领先企业通常透过临床证据、植入可靠性和全面的服务项目来脱颖而出，这些项目包括实践培训、模拟模组和能力检验。新兴企业专注于特定领域的优势，例如针对儿科患者优化的符合人体工学设计、适用于空中救护运输的超紧凑型设计，以及用于辅助库存管理和临床记录的整合遥测和追踪功能。

为了整合分销实力、临床培训能力和生产规模，伙伴关係和策略联盟正变得越来越普遍。契约製造和目的地设备製造商 (OEM) 关係使技术驱动型新参与企业能够加速市场进入，同时减少生产设施的资本投入。同时，采购部门和大型医疗系统透过优先选择那些能够提供长期采购协议、供应链透明度和完善的上市后监管的供应商，获得了谈判优势。总而言之，竞争成功取决于始终如一的价值提案，该主张将差异化的设备性能与循证结果、法规遵从性和可扩展的服务相结合。

为製造商和医疗系统领导者提供切实可行的策略蓝图，以确保骨内装置的临床应用、供应连续性和基于实证医学的差异化。

为了赢得临床信任和采购优先权，产业领导者应采取多层次策略，平衡创新与业务连续性。首先，优先产生高品质的临床证据，证明产品能够提高首次手术成功率、减少植入併发症并显着提升工作流程效率。这些证据应支持产品声明，并纳入临床医生培训课程。其次，透过对替代组件供应商进行资格认证和评估区域製造伙伴关係关係，实现供应链多元化，从而降低关税衝击和物流中断的风险。第三，设计可配置的产品系列和模组化培训项目，以满足从门诊手术中心和诊所到空中救护队和战地医疗支援部队等不同终端用户的需求。

此外，还需要投资于售后服务和数位化工具，以加强设备追踪、功能评估和真实世界证据收集。这些服务可以巩固客户关係，并为报销谈判提供支援。积极与支付者、医疗系统和监管机构沟通，明确医疗设备分类，简化推广路径。最后，将政策变化和供应中断的情境规划纳入商业合约和库存管理，以确保在风险较高时期临床服务的连续性。落实这些措施将使製造商和经销商能够减少采购摩擦，加速临床应用，并在不断变化的环境中保持收入稳定。

采用透明的混合方法研究设计，整合了对临床医生的访谈、监管审查和供应链分析，以产生经证实有效的营运洞察。

本分析的研究途径结合了与关键相关人员的初步定性研究、对监管和临床文献的系统性回顾以及有针对性的供应链分析，以确保获得可靠且可操作的见解。初步研究包括对急诊室、加护病房、空中救护服务、野战医疗队和门诊手术中心的临床医生进行结构化访谈，以及与采购经理、培训计画主管和生产合作伙伴进行讨论。这些对话旨在揭示医疗设备性能优先事项、培训差距、采购标准和供应链薄弱环节。

二次研究回顾了临床指南、医疗设备使用说明书、监管申报文件和已发布的上市后监测摘要，以支持临床医生报告的发现并了解医疗设备的安全性。供应链分析绘製了关键组件供应商、製造地和物流路线图，以评估关税变化带来的风险并确定切实可行的缓解策略。在适当情况下，研究结果透过多方资讯来源的检验和专家小组审查得到验证。调查方法包括机构层级采购合约的可用性不一以及培训项目的采用率存在差异。透过纳入不同类型的受访者并清楚记录不确定因素，供读者在决策时参考，这些限制得到了缓解。

整合临床、技术和营运因素，以明确骨内输液装置在急性照护环境中的永续价值提案

骨内输注装置是一个日益成熟但仍在不断发展的领域，它融合了急诊需求、技术创新和复杂的采购动态。其普及轨迹更取决于临床证据、供应链韧性、训练支援和监管完整性等因素所构成的生态系统，而非单一产品的特性。能够整合这些要素并提供一致的价值提案（包括可证实的临床获益、可靠的供应和终端用户培训）的利益相关人员，将最有希望在急诊医学、加护治疗、门诊手术和军事应用领域获得持续的普及。

展望未来，随着政策和贸易趋势持续影响采购决策和成本结构，多元化和区域製造能力将成为重要的策略槓桿。同样，医疗设备人体工学设计、插入可靠性以及模拟训练等综合服务的持续改进，将降低使用障碍并扩大临床适应症。最终，製造商和医疗系统的成功将取决于能否将技术性能转化为可衡量的临床结果和营运可预测性，从而确保临床医生在时间紧迫、就医难时拥有提供紧急医疗所需的工具和信心。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 引入一种电池驱动的自动骨内输液系统，用于在紧急医疗环境中快速建立血管通路。
• 将智慧感测器技术整合到骨内输液装置中，以监测流速并预防併发症。
• 医疗设备製造商与创伤中心合作，改进骨内输液设备的设计和培训
• 儿童和成人患者对可同时进行液体输注的多部位骨内通路装置的需求日益增长。
• 监管部门的核准和临床试验结果推动了新一代骨内输液针的商业化进程
• 增加对微创骨内导管研发的投资，该导管采用增强型生物相容性涂层，用于感染控制。
• 拓展照护现场于军事和恶劣环境的床边骨内输液解决方案，以改善战场创伤照护。
• 继续研究超细骨内针，以减轻插入疼痛并加快儿科急救復苏速度。
• 开发一种具有预充式生理食盐水锁和自动压力监测系统的整合式骨内输液套件
• 利用扩增实境（AR）技术指导，扩展远距骨内输液培训的远距教学项目

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的骨内输注设备市场

• 电池式钻孔机
• 手动针
• 气动
• 弹簧式自动插入装置

9. 依最终用户分類的骨内输液装置市场

• 门诊治疗中心
  • 门诊手术中心
  • 医生诊所
• 紧急医疗服务
  • 空中救护
  • 院前急救服务
• 医院
  • 急诊室
    • 成人急诊室
    • 儿科急诊
  • 加护病房（ICU）
    • 成人加护病房
    • 新生儿加护病房
    • 儿科加护病房
  • 手术室
    • 一般外科
    • 整形外科
• 军队
  • 战斗支援医院
  • 野战医疗队

10. 依技术分類的骨内输液装置市场

• 电池供电
  • 可充电电池
  • 免洗电池供电
• 手动输入
• 气动
  • 气动
  • 汽油动力
• 弹簧机构

第十一章 依应用分類的骨内输液装置市场

• 心臟麻痹
  • 在医院里
  • 医院外
• 肿瘤学
  • 骨髓切片检查
  • 化疗支持
• 整形外科
  • 骨折修復
  • 关节重建
• 孩子们
  • 孩子们
  • 婴儿
  • 新生
• 创伤
  • 钝性创伤
  • 穿透性创伤

第十二章 骨内输注装置市场（依适应症划分）

• 心臟麻痹
• 低血容性休克
• 败血症
• 创伤

13. 按地区分類的骨内输液装置市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 骨内输液装置市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

15. 各国骨内输液装置市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Cook Group Incorporated
  • Vygon SA
  • ICU Medical, Inc.
  • Smiths Group plc
  • B. Braun Melsungen AG
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Waismed Strategic Technologies Ltd.

The Intraosseous Infusion Devices Market is projected to grow by USD 9.01 billion at a CAGR of 6.51% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 5.43 billion
Estimated Year [2025]	USD 5.79 billion
Forecast Year [2032]	USD 9.01 billion
CAGR (%)	6.51%

Introducing the clinical and commercial imperative driving intraosseous infusion device adoption across high-acuity care settings and operational environments

Intraosseous infusion devices occupy a critical niche in acute care delivery where vascular access is essential and time-sensitive. Clinicians rely on these devices to establish reliable intramedullary access when peripheral veins are inaccessible or when rapid resuscitation is required, and their adoption spans emergency departments, pre-hospital settings, operating theatres, critical care units, and military field medicine. Technological evolution has moved the field beyond basic manual needles to mechanized insertion systems and battery-driven drills designed to reduce insertion time and variability and to improve first-attempt success rates in high-stress clinical scenarios.

This introductory analysis frames the clinical need, technological differentiation, and procurement considerations that shape device selection and adoption. It underscores the interplay between device ergonomics, insertion reliability, clinician training, and downstream workflows such as fluid resuscitation, drug delivery, and diagnostic sampling. The objective is to provide a succinct orientation for clinicians, procurement leaders, and product strategists so they can evaluate how device characteristics align with care pathways, regulatory demands, and operational constraints. By setting this context, the subsequent sections explore structural shifts, tariff implications, segment-level insights, regional dynamics, competitive behaviors, and practical recommendations grounded in primary and secondary intelligence.

How technological innovation, clinician training evolution, and supply chain resilience are collectively redefining intraosseous device selection and clinical utilization

The intraosseous device landscape is experiencing a series of transformative shifts that reshape product design priorities, purchase criteria, and clinical workflows. Advances in insertion mechanisms and portability are narrowing the gap between in-hospital and pre-hospital capabilities, and next-generation devices increasingly emphasize single-handed operation, controlled depth insertion, and integrated safety features to limit complications and to streamline training. At the same time, procurement teams demand devices that deliver consistent performance across diverse patient populations, including adults, pediatrics, neonates, and geriatric patients, prompting manufacturers to broaden product portfolios and to introduce modular systems.

Concurrently, the supply chain and manufacturing strategies that underpin device availability have moved toward regionalization and component redundancy to mitigate disruption risk. Insurers and health systems are placing greater emphasis on care quality metrics and device-related adverse event reporting, which elevates clinical evidence generation and post-market surveillance as differentiating factors. Moreover, the diffusion of simulation-based training and competency validation programs has accelerated clinician confidence and first-pass success, which in turn supports wider adoption across emergency medical services and ambulatory surgical settings. These converging trends create opportunities for manufacturers to innovate on user experience, service offerings, and evidence packages while also compelling purchasers to evaluate total cost of ownership, clinical outcomes, and lifecycle support.

Assessing how anticipated tariff dynamics could influence sourcing strategies, manufacturing localization, and clinical availability of intraosseous infusion devices

Since tariff policy changes can cascade through complex medtech supply chains, potential United States tariff actions in 2025 introduce a layer of policy risk that stakeholders must evaluate across sourcing, manufacturing, and procurement. Tariffs that target device components or finished devices create immediate cost pressure for organizations that rely on imported instrumentation or raw materials, prompting procurement teams to reassess supplier contracts, inventory buffers, and domestic sourcing options. In response, some manufacturers may accelerate localization of critical manufacturing steps or deepen relationships with domestic contract manufacturers to preserve price stability and delivery timelines.

Beyond direct price effects, tariffs influence strategic choices such as product configuration, packaging, and the geographic routing of shipments to minimize duty exposure. Distributors and group purchasing organizations may seek revised contract clauses that allocate tariff-related cost changes, while health systems may adjust acquisition timelines to exploit existing inventory or negotiated pricing. Importantly, tariffs can also spur investment in alternative supply chains for key components like motors, batteries, and specialized alloys, which has implications for device design and lead times. From a clinical perspective, policy-driven supply interruptions risk constraining device availability in high-acuity moments, making redundancy and contingency planning essential. Taken together, tariff dynamics encourage a proactive posture among manufacturers and buyers to diversify sourcing, to validate alternative suppliers, and to formalize escalation procedures that preserve clinical continuity and mitigate operational risk.

Segment-level analysis revealing how device type, end-user environment, technology choices, clinical applications, and indications drive differentiated procurement and adoption dynamics

A granular segmentation lens reveals how device technology and end-user contexts dictate product requirements and adoption pathways. Based on Device Type, stakeholders evaluate options that include Battery Powered Drill, Manual Needles, Pneumatic, and Spring Loaded Auto Insert, with each configuration presenting distinct trade-offs in speed, control, and user learning curve. Based on End User, the spectrum of settings includes Ambulatory Care Centers, Emergency Medical Services, Hospitals, and Military; within Ambulatory Care Centers the focus narrows to Outpatient Surgical Centers and Physician Clinics, while Emergency Medical Services encompasses Air Ambulance and Pre-Hospital Emergency Services. Hospitals unpack further into Emergency Department, ICU, and Operating Room contexts; the Emergency Department itself splits into Adult Emergency Department and Pediatric Emergency Department, and the ICU delineates Adult ICU, Neonatal ICU, and Pediatric ICU. Operating Room use cases divide into General Surgery and Orthopedic Surgery, whereas Military applications differentiate between Combat Support Hospitals and Field Medical Units.

From a technology standpoint, device choice aligns with the performance envelope required for specific settings. Based on Technology, the market includes Battery Powered, Manual, Pneumatic, and Spring Mechanism devices, with Battery Powered solutions further segmented into Rechargeable Battery and Single Use Battery options, and Pneumatic systems differentiated by Air Driven and Gas Driven variants. Application-specific requirements further refine product selection. Based on Application, clinicians select devices for Cardiac Arrest, Oncology, Orthopedics, Pediatrics, and Trauma, where Cardiac Arrest use occurs both In-Hospital and Out-Of-Hospital, Oncology supports Bone Marrow Biopsy and Chemotherapy Support, Orthopedics addresses Fracture Repair and Joint Replacement, Pediatrics spans Child, Infant, and Neonatal populations, and Trauma care must cover Blunt and Penetrating injuries. Finally, clinical indication profiles matter deeply. Based on Indication, device deployment is guided by conditions such as Cardiac Arrest, Hypovolemic Shock, Sepsis, and Trauma, each carrying unique procedural timing, access site considerations, and downstream therapy needs. Synthesizing these segmentation axes clarifies that a one-size-fits-all product rarely satisfies diverse use cases, and that tailored design, training, and support models are critical to adoption.

How regional regulatory, procurement, and clinical training differences in major global regions recalibrate product strategies and distribution models for intraosseous devices

Regional dynamics play a decisive role in shaping regulatory pathways, reimbursement frameworks, training ecosystems, and supply chain architectures for intraosseous devices. In the Americas, buyers emphasize rapid emergency care integration, wide availability of simulation training centers, and concentrated procurement through integrated health systems and large distributors, which favors devices with strong clinical evidence and scalable service models. In Europe, Middle East & Africa the regulatory mosaic and heterogeneous reimbursement practices create diverse entry conditions; European markets often prioritize clinical outcomes and post-market vigilance while Middle Eastern and African settings place a higher premium on device robustness and supply continuity, especially for remote or austere environments. In Asia-Pacific, rapid hospital expansion, increasing emergency care capacity, and significant military modernization programs create growing demand, but market access strategies must account for varied regulatory requirements, local manufacturing incentives, and differing clinician training norms.

Across these regions, local manufacturing capacity, tariff regimes, and logistics infrastructure influence lead times and inventory strategies. Regional purchasing consortia and tender processes can advantage manufacturers that offer transparent lifecycle support and training partnerships. Moreover, clinical guideline adoption and pre-hospital care models vary by region, which affects the segmentation of devices between in-hospital emergency departments and pre-hospital or military deployments. Consequently, successful regional strategies require tailored value propositions that align device features with local clinical workflows, regulatory expectations, and procurement mechanisms.

Competitive landscape analysis showing how evidence, training, and supply chain partnerships determine commercial success for intraosseous device providers

Competitive positioning within the intraosseous device segment reflects a mix of established device manufacturers, technology-focused entrants, and service-oriented providers that bundle training and post-market support with hardware sales. Leading players typically differentiate on clinical evidence, insertion reliability, and comprehensive service programs that include hands-on training, simulation modules, and competency validation. Emerging companies focus on niche advantages such as optimized ergonomics for pediatric populations, ultra-compact designs for air ambulance use, or integrated telemetry and tracking features that support inventory management and clinical documentation.

Partnerships and strategic alliances are increasingly common as companies seek to combine distribution strengths, clinical training capabilities, and manufacturing scale. Contract manufacturing and original equipment manufacturer relationships allow technology-focused entrants to accelerate market entry while mitigating capital investment in production facilities. Meanwhile, procurement groups and large health systems exert negotiating leverage through long-term purchasing agreements and by prioritizing suppliers who demonstrate supply chain transparency and robust post-market surveillance. Overall, competitive success depends on a coherent value proposition that pairs differentiated device performance with evidence-based outcomes, regulatory compliance, and scalable service delivery.

Actionable strategic blueprint for manufacturers and health system leaders to secure clinical adoption, supply continuity, and evidence-based differentiation in intraosseous devices

Industry leaders should adopt a multi-layered strategy that balances innovation with operational resilience to capture clinical trust and procurement preference. First, prioritize generation of high-quality clinical evidence that demonstrates improved first-attempt success rates, reduced insertion complications, and measurable workflow efficiencies; this evidence should underpin product claims and be integrated into clinician training curricula. Second, diversify supply chains by qualifying alternate component suppliers and by evaluating regional manufacturing partnerships to reduce exposure to tariff shocks and logistics disruptions. Third, design configurable product portfolios and modular training programs that address the needs of distinct end users, from ambulatory surgical centers and physician clinics to air ambulance teams and combat support medical units.

Additionally, invest in post-market services and digital tools that enhance device tracking, competency assessment, and real-world evidence collection; these services strengthen customer relationships and support reimbursement discussions. Engage proactively with payers, health systems, and regulatory authorities to clarify device classifications and to streamline adoption pathways. Finally, embed scenario planning for policy shifts and supply interruptions into commercial contracts and inventory practices so that clinical continuity remains protected during periods of heightened risk. By operationalizing these steps, manufacturers and distributors can reduce procurement friction, accelerate clinical acceptance, and preserve revenue stability in an evolving landscape.

Transparent mixed-methods research design integrating primary clinician interviews, regulatory review, and supply chain mapping to produce validated operational insights

The research approach underpinning this analysis combines primary qualitative engagement with key stakeholders, systematic review of regulatory and clinical literature, and targeted supply chain mapping to ensure robust, actionable insights. Primary research included structured interviews with practicing clinicians across emergency departments, intensive care units, air ambulance services, field medical units, and outpatient surgical centers, as well as discussions with procurement leaders, training program directors, and manufacturing partners. These conversations were designed to surface device performance priorities, training gaps, procurement criteria, and supply chain vulnerabilities.

Secondary research encompassed review of clinical guidelines, device instruction sets, regulatory filings, and published post-market surveillance summaries to corroborate clinician-reported outcomes and to understand device safety profiles. Supply chain analysis mapped key component suppliers, manufacturing footprints, and logistics routes to evaluate exposure to tariff changes and to identify practical mitigation options. Where appropriate, findings were validated through triangulation across multiple sources and via expert panel review. Methodological limitations include variable availability of institution-level procurement contracts and heterogeneity in training program adoption rates, which were mitigated by sourcing diverse respondent types and by clearly documenting areas of uncertainty for readers to consider in decision-making.

Synthesis of clinical, technological, and operational drivers defining the enduring value proposition for intraosseous infusion devices in acute care

Intraosseous infusion devices are a mature but evolving category that sits at the intersection of acute clinical need, technological innovation, and complex procurement dynamics. The trajectory of adoption is shaped less by single product attributes and more by an ecosystem of clinical evidence, supply chain resilience, training support, and regulatory alignment. Stakeholders who can synthesize these elements into coherent value propositions-providing demonstrable clinical benefits, reliable supply, and end-user training-will be best positioned to win durable adoption across emergency medicine, critical care, outpatient surgical settings, and military applications.

Looking ahead, policy and trade dynamics will continue to affect sourcing decisions and cost structures, making diversification and localized capacity valuable strategic levers. Equally, ongoing improvements in device ergonomics, insertion reliability, and integrated services such as simulation-based training will lower barriers to use and expand clinical indications. Ultimately, success for manufacturers and health systems alike depends on translating technical performance into measurable clinical outcomes and operational predictability, thereby ensuring that clinicians have the tools and confidence needed to deliver lifesaving care when time and access matter most.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Adoption of battery-powered automated intraosseous infusion systems in emergency care settings for faster vascular access
• 5.2. Integration of smart sensor technology in intraosseous infusion devices to monitor flow rates and prevent complications
• 5.3. Collaborative partnerships between medical device companies and trauma centers to refine intraosseous device design and training
• 5.4. Growing demand for multi-site intraosseous access devices enabling simultaneous infusions in pediatric and adult patients
• 5.5. Regulatory approvals and clinical trial outcomes driving commercialization of next-generation intraosseous infusion needles
• 5.6. Rising investment in developing minimally invasive intraosseous catheters with enhanced biocompatible coatings for infection control
• 5.7. Expansion of point-of-care intraosseous infusion solutions in military and austere environments to improve battlefield trauma care
• 5.8. Ongoing research into ultra-thin intraosseous needles to reduce insertion pain and accelerate emergency pediatric resuscitation
• 5.9. Development of integrated intraosseous infusion kits with prefilled saline lock and automated pressure monitoring systems
• 5.10. Increase in tele-mentoring programs for remote intraosseous infusion training using augmented reality guidance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraosseous Infusion Devices Market, by Device Type

• 8.1. Battery Powered Drill
• 8.2. Manual Needles
• 8.3. Pneumatic
• 8.4. Spring Loaded Auto Insert

9. Intraosseous Infusion Devices Market, by End User

• 9.1. Ambulatory Care Centers
  • 9.1.1. Outpatient Surgical Centers
  • 9.1.2. Physician Clinics
• 9.2. Emergency Medical Services
  • 9.2.1. Air Ambulance
  • 9.2.2. Pre-Hospital Emergency Services
• 9.3. Hospitals
  • 9.3.1. Emergency Department
    • 9.3.1.1. Adult Emergency Department
    • 9.3.1.2. Pediatric Emergency Department
  • 9.3.2. ICU
    • 9.3.2.1. Adult ICU
    • 9.3.2.2. Neonatal ICU
    • 9.3.2.3. Pediatric ICU
  • 9.3.3. Operating Room
    • 9.3.3.1. General Surgery
    • 9.3.3.2. Orthopedic Surgery
• 9.4. Military
  • 9.4.1. Combat Support Hospitals
  • 9.4.2. Field Medical Units

10. Intraosseous Infusion Devices Market, by Technology

• 10.1. Battery Powered
  • 10.1.1. Rechargeable Battery
  • 10.1.2. Single Use Battery
• 10.2. Manual
• 10.3. Pneumatic
  • 10.3.1. Air Driven
  • 10.3.2. Gas Driven
• 10.4. Spring Mechanism

11. Intraosseous Infusion Devices Market, by Application

• 11.1. Cardiac Arrest
  • 11.1.1. In-Hospital
  • 11.1.2. Out-Of-Hospital
• 11.2. Oncology
  • 11.2.1. Bone Marrow Biopsy
  • 11.2.2. Chemotherapy Support
• 11.3. Orthopedics
  • 11.3.1. Fracture Repair
  • 11.3.2. Joint Replacement
• 11.4. Pediatrics
  • 11.4.1. Child
  • 11.4.2. Infant
  • 11.4.3. Neonatal
• 11.5. Trauma
  • 11.5.1. Blunt
  • 11.5.2. Penetrating

12. Intraosseous Infusion Devices Market, by Indication

• 12.1. Cardiac Arrest
• 12.2. Hypovolemic Shock
• 12.3. Sepsis
• 12.4. Trauma

13. Intraosseous Infusion Devices Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Intraosseous Infusion Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Intraosseous Infusion Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Becton, Dickinson and Company
  • 16.3.2. Teleflex Incorporated
  • 16.3.3. Cook Group Incorporated
  • 16.3.4. Vygon SA
  • 16.3.5. ICU Medical, Inc.
  • 16.3.6. Smiths Group plc
  • 16.3.7. B. Braun Melsungen AG
  • 16.3.8. Merit Medical Systems, Inc.
  • 16.3.9. Nipro Corporation
  • 16.3.10. Waismed Strategic Technologies Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. INTRAOSSEOUS INFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. INTRAOSSEOUS INFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INTRAOSSEOUS INFUSION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 261. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 262. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 263. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
• TABLE 264. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
• TABLE 265. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 266. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 267. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 268. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 269. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 273. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 274. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 279. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 280. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 281. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 282. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 283. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
• TABLE 284. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
• TABLE 285. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 286. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 287. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRI